ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1522 National Cancer Institute Html en Childhood Brain Stem Glioma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood brain stem glioma.
PDQ Childhood Brain0.262624
cancer treatment0.317391
new cancer cells0.250632
brain stem glioma0.990842
metastatic brain tumors0.262145
type0.250835
PDQ cancer information0.305049
clinical trial search0.257718
brain tumors0.389165
children0.259907
clinical trials0.541127
health care providers0.255221
Pediatric Treatment Editorial0.256101
cancer information summary0.282392
clinical trial0.361183
patients0.252235
NCI PDQ cancer0.25809
radiation therapy0.3037
Treatment Editorial Board0.258484
intrinsic pontine glioma0.314731
focal childhood brain0.250848
late effects0.256779
treatment0.494086
focal glioma0.286058
cancer cells0.359639
brain stem gliomas0.410944
primary brain tumors0.262357
PDQ Pediatric Treatment0.253085
signs0.25352
Benign brain tumors0.261631
treatment clinical trials0.275821
National Cancer Institute0.282821
following PDQ treatment0.270231
effects cancer treatment0.263814
new treatment0.290537
childhood cancer information0.253956
childhood brain tumors0.305915
BRAF kinase0.259925
treatment clinical trial0.25851
PDQ summary0.250138
Malignant brain tumors0.261555
cancer clinical trials0.275926
focal brain stem0.331856
treatment options0.261824
brain tissue0.259205
cancer0.498153
standard treatment0.287654
BRAF kinase inhibitor0.253173
childhood brain stem0.659927
CLICK HERE
1545 National Cancer Institute Html en Adult Hodgkin Lymphoma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.
red blood cells0.404993
cancer treatment0.406441
body0.406679
PDQ cancer information0.415705
unfavorable Hodgkin lymphoma0.403766
Non-Hodgkin Lymphoma Treatment0.396504
clinical trial search0.387461
pregnant women0.365816
favorable Hodgkin lymphoma0.403909
white blood cells0.390827
favorable adult Hodgkin0.379079
unfavorable adult Hodgkin0.379392
clinical trials0.634552
lymph nodes0.463894
cancer information summary0.39389
clinical trial0.489293
stem cell transplant0.415484
recurrent Hodgkin lymphoma0.402776
adult hodgkin lymphoma0.802336
patients0.379207
blood cells0.446195
weight loss0.391968
NCI PDQ cancer0.365284
radiation therapy0.587067
Nodular sclerosing Hodgkin0.384149
lymph node groups0.460532
treatment0.56475
night sweats0.39371
Hodgkin Lymphoma Treatment0.422215
cancer cells0.401875
cellularity Hodgkin lymphoma0.419706
swollen lymph nodes0.429808
treatment clinical trials0.386111
National Cancer Institute0.39221
lymph vessels0.383555
new treatment0.393163
advanced hodgkin lymphoma0.435901
Hodgkin lymphomas0.368401
classical Hodgkin lymphoma0.419308
bone marrow0.427904
depletion Hodgkin lymphoma0.419209
sedimentation rate0.371778
hodgkin lymphoma0.94955
cancer clinical trials0.401646
stage0.410094
Combination chemotherapy0.415703
cancer0.682215
information0.416232
appropriate cancer treatment0.37213
CLICK HERE
1600 National Cancer Institute Html en Nutrition in Cancer Care (PDQ®)–Patient Version Expert-reviewed information summary about the causes and management of nutritional problems that occur in patients with cancer.
cancer treatment0.815724
foods0.591336
body0.50774
PDQ cancer information0.539768
general health0.483553
mouth sores0.564301
nutrition problems0.511061
cancer information summary0.514016
Cancer Care section0.490312
enteral nutrition0.493173
cancer care0.499373
cancer patients0.772982
weight loss0.581589
dry mouth0.559356
NCI PDQ cancer0.489458
nutrition0.675709
effects0.559624
good nutrition0.476052
nutrition therapy0.671346
radiation therapy0.583611
Advanced Cancer section0.512145
nutrition support care0.489001
cancer treatments0.531014
parenteral nutrition support0.491942
cancer prevention0.486895
cancer cells0.480334
Cancer Information Service0.511605
palliative care0.476957
nutrients0.514961
certain foods0.495203
parenteral nutrition0.492581
National Cancer Institute0.539267
advanced cancer0.530168
white blood cell0.522179
fight infection0.479873
low white blood0.494372
breast cancer0.518198
cancer patients control0.508745
health0.485589
food0.567108
PDQ summary0.508916
Eat foods0.503278
following nutrition problems0.482655
mouth0.591038
cancer information summaries0.483904
comprehensive cancer information0.47883
cancer0.980934
information0.558957
Cancer survivors0.484253
CLICK HERE
1718 National Cancer Institute Html en Pap and HPV Testing A fact sheet that describes the Pap and HPV tests, possible results from those tests, and the link between HPV and cervical cancer.
Pap test results0.318639
precancerous cervical lesions0.292159
squamous cells0.289348
high-risk HPV0.671741
First-line HPV testing0.290741
squamous cell abnormalities0.296427
primary HPV screening0.318981
cervical screening0.408649
glandular cell abnormalities0.323902
professional cervical cancer0.287037
cervical cells0.449089
Pap test0.978312
HPV testing0.403472
frequent cervical screening0.280097
cell abnormalities0.445026
HPV test0.442688
negative HPV test0.307642
cervical cancer screening0.819575
positive HPV test0.337496
cervical cancer0.958343
HPV DNA test0.30151
Pap cytology test0.279358
early cervical cancers0.308324
HPV infections0.362202
HPV test results0.327074
abnormal cells0.314778
abnormal cervical cells0.343301
precancerous cervical lesion0.309268
HPV0.765136
Pap test result0.433853
different HPV tests0.296834
cervical cell abnormalities0.361261
cobas HPV test0.304363
high-risk HPV types0.661339
additional high-risk HPV0.303577
new cervical cancers0.27692
high-risk HPV type0.405337
cervical cancer risk0.324311
HPV cotesting0.335213
liquid-based Pap cytology0.286767
future cervical cancer0.287194
abnormal Pap test0.300522
HPV infection0.371378
cells0.464647
regular cervical screening0.330087
Routine cervical screening0.314661
Pap testing0.293059
cell changes0.293167
CLICK HERE
1935 National Cancer Institute Html es Tratamiento del ependimoma infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del ependimoma infantil.
radiocirugía estereotáctica0.685192
siguientes procedimientos0.332065
efectos secundarios meses0.562136
siguientes áreas0.378745
huesos dorsales0.375848
general recidiva0.34956
efectos tardíos0.729968
PDQ Efectos tardíos0.453185
cabo irm0.352274
líquido cefalorraquídeo0.982409
punción espinal.Ampliar0.373407
estudio clínico0.337757
National Cancer Institute0.329628
siguientes riesgos0.321782
Instituto Nacional0.357335
PDQ Tratamiento0.392525
determinados cambios0.326515
gen rela0.670707
nuevos tipos0.348217
siguientes factores0.370167
sistema nervioso central0.663463
Physician Data Query0.423559
segura.ampliar craneotomía0.353248
cuánto tumor0.478632
siguientes sumarios0.438618
CLICK HERE
1945 National Cancer Institute Html es Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de los problemas de salud que aparecen una vez que termina el tratamiento del cáncer.
cancer statistics0.312893
among adult survivors0.309342
health insurance0.30576
childhood leukemia survivors0.314627
Marrow Transplant Survivor0.306695
largo plazo0.353459
Cancer Survivor cohort0.310798
CA Cancer0.308516
group long-term follow-up0.307764
mortality among 5-year0.309974
health conditions0.3067
young adult cancers0.387348
late mortality0.309117
Ness KK0.312945
among childhood cancer0.329959
adult survivors0.341543
Hudson MM0.322937
among survivors0.313213
British Childhood Cancer0.315849
utilization among long-term0.306183
childhood cancer0.973475
cancer survivor study0.608871
late effects0.312383
SEER Cancer Statistics0.308306
long-term survivors0.338777
health care utilization0.307102
Survivor Study cohort0.310239
chronic health conditions0.305835
among adolescent survivors0.308292
Care Cancer0.309376
among 5-year survivors0.328567
Pediatr Blood Cancer0.42011
oncology group long-term0.310223
adolescent cancers0.313982
efectos tardíos0.375703
survivors research program0.306998
report from0.396085
National Cancer Institute0.308232
Oeffinger KC0.306859
health care0.314251
mortality among survivors0.308816
Clin Oncol0.375569
childhood cancer survivor0.872407
medical care0.307228
among long-term survivors0.315379
late mortality among0.306982
long-term follow-up guidelines0.320022
Outcomes Among Childhood0.309917
children's oncology group0.433388
CLICK HERE
3576 National Cancer Institute Html en Cancer Prevention Research NCI’s prevention research has a broad focus, from identifying environmental and lifestyle factors that influence cancer risk to studying the biology of how cancer develops and studying ways to disseminate prevention interventions.
potential preventive therapies0.441911
cancer prevention trials0.552513
Drug Development Program0.440287
PREVENT Cancer Preclinical0.524374
higher cancer rates0.5328
public health imperative0.449962
Tobacco Control Research0.447635
tobacco control programs0.463087
invasive cancer0.460548
specific population groups0.436493
behavioral risk factors0.665388
cancer care0.47747
NCI’s Division0.485356
cervical cancer0.456337
Reduce Cancer Health0.518587
FDA-approved HPV vaccines—work0.439068
NCI’s Center0.488421
Cancer Epidemiology0.455548
prevention-focused clinical studies0.444916
cancer health disparities0.673431
Cancer Control0.456877
risk reduction0.469434
cancer screening0.48636
cancer prevention0.875489
United States0.669252
new cancer prevention0.553181
annual cancer-related deaths0.450355
Cancer Research0.477162
studies0.468685
HPV-associated cancer0.458082
cancer researchers0.479223
substantially increased risk0.487266
prevention research efforts0.4695
HPV vaccine trials0.440028
NCI Community Oncology0.488471
new preventive therapy0.454621
cancer development0.485138
people0.446203
cancer prevention research0.671334
cancer disparities0.497724
physical activity0.439301
bivalent HPV vaccine0.436545
Cancer Prevention Clinical0.54727
NCI Cohort Consortium0.479534
cancer risk0.971388
cancer0.983944
cancer incidence0.537166
genome-wide association studies0.438797
CLICK HERE
3876 National Cancer Institute Html en The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for the NCI F99/K00 Award that helps late-stage doctoral candidates finish their training and then transition into cancer-focused research positions.
K00 phase institution0.388613
applicant institution0.265884
Research Doctoral candidates0.275389
Funding Opportunity Announcement0.903132
research supplies0.244496
Career Development Award0.350987
k00 award0.331719
Ph.D. dissertation requirements0.237088
phase institutional representative0.335728
project award period0.253621
indirect costs0.425626
NCI F99/K00 Predoc0.307817
Institutional Allowance0.281782
Career Development Support0.249362
Research Career Development0.347168
k00 phase0.762118
Research Plan section0.261319
career development skills0.241364
health-related Ph.D. program0.243519
F99 primary sponsor0.23706
Research Service Award0.312163
Individual Research Career0.265006
mandatory NCI-sponsored conference0.307767
Opportunity Announcement instructions0.260896
career development research0.317687
dissertation research project0.396866
Ph.D. degree program0.256222
valid U.S. visas0.237157
Postdoctoral Fellow Transition0.248842
Application Guide0.311615
NCI Predoctoral0.237727
F99 phase0.471921
dissertation research training0.299174
program staff0.238571
Program Staff Contact0.236142
Research Strategy0.247855
F99/K00 Award0.359733
F99 grant mechanism0.235643
assigned NCI Program0.270275
Development Award Supplemental0.254853
F99 award0.269956
fringe benefits0.272186
valid U.S. visa0.254123
career development0.562023
Research Plan Sections0.252481
Fellowship Applicant Section0.257658
F99/K00 Award application0.300758
health-related research field0.279872
Postdoctoral Research Direction0.273719
CLICK HERE
15846 National Cancer Institute Html en RAS Biochemistry and Biophysics This RAS Biochemistry and Biophysics lab investigates signaling by RAS proteins, which is regulated by the interactions with substrates, protein partners, and membranes.
cell membranes0.473685
Nuclear Magnetic Resonance0.585708
Biophysics Group team0.636374
mutant RAS0.650163
KRAS proteins0.677168
nanodiscs0.374828
cancer deaths0.469996
fully modified KRAS0.804703
different cancers0.503399
Washington University0.469252
analytical ultracentrifugation0.487353
protein-nanodisc complexes0.475228
atomic levels0.48075
stephena@mail.nih.gov0.45777
Ridge National Laboratory0.591017
Rodolfo Ghirlando0.472711
artificial lipid bilayers0.682865
KRAS4b protein0.638588
sensitive techniques0.481762
Carla Mattos0.458864
California0.350663
Northeastern University0.475122
RAS proteins0.703869
neutron scattering0.468073
RAS Biochemistry0.737959
different KRAS0.64483
different lipid compositions0.713219
Chris Stanley0.450409
fully modified KRAS4b0.914598
Jay Groves0.463932
interactions0.440981
intrinsic hydrolysis rates0.625326
numerous interacting partner0.64654
inner plasma membrane0.635847
Marco Tonelli0.478206
surrogate0.33572
St. Louis0.448878
Digestive Kidney Dieases0.603479
National Institute0.589812
Paul Henderson0.462542
single molecule analysis0.605131
different mutant proteins0.699255
dozen different mutants0.686498
biophysical assays0.484191
binding affinities0.477155
Steve Sligar0.461855
biophysics group0.812528
major oncogenic mutants0.687098
KRAS account0.631848
CLICK HERE
15877 National Cancer Institute Html es Antineoplastones (PDQ®)–Versión para pacientes Resumen de información revisada por expertos sobre los antineoplastones como tratamiento para personas con cáncer.
corta duración0.52325
suficientes antineoplastones0.570315
Centro Nacional0.534282
New Hampshire Avenue0.523956
cabo ensayos0.607081
Drug Administration0.514884
antineoplastones a100.621411
NCI Best Case0.546794
siguientes tipos0.528576
PDQ Antineoplastones0.580269
datos bibliográficos pubmed0.525907
siguientes preguntas0.515649
fase ii0.701787
células tumorales animales0.553458
National Cancer Institute0.529942
siguientes riesgos0.520138
seguro médico0.513988
Instituto Nacional0.710175
Salud Complementaria0.553301
Visuals Online0.517781
complementarias revisa0.52541
Physician Data Query0.604461
antineoplastones a20.575169
Estados Unidos0.855832
corto plazo0.520833
libre uso0.517405
página manejo0.516526
¿El tratamiento0.536286
Clínica Mayo0.524069
¿Los beneficios0.515122
juntos cam0.514422
Series Program0.514906
medicina complementaria0.99587
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.